Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts)
Year: 2013
Type: conference-abstract
Source: ORBi (University of Liège)
Institutions: Hôpital Necker-Enfants Malades, Centre Hospitalier Universitaire de Nantes, The Ohio State University, Hospital Universitario Reina Sofía, Houston Methodist, Medizinische Hochschule Hannover, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Centre Hospitalier Universitaire de Lille, Assistance Publique – Hôpitaux de Paris, Hôpital Tenon, Mario Negri Institute for Pharmacological Research, Centre Hospitalier Universitaire de Liège, Alexion Pharmaceuticals (United States), Université Paris Descartes
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1908862090
